CD16+ fibroblasts foster a trastuzumab-refractory microenvironment that is reversed by VAV2 inhibition
Xinwei Liu, Yiwen Lu, Jingying Huang, Yue Xing, Huiqi Dai, Liling Zhu, Shunrong Li, Jingwei Feng, Boxuan Zhou, Jiaqian Li, Qi‐Dong Xia, Jiang Li, Min Huang, Yuanting Gu, Shicheng Su
Topics & Concepts
TrastuzumabCD16Cancer researchBiologyCell biologyChemistryImmunologyMedicineCancerInternal medicineBreast cancerImmune systemCD3CD8Monoclonal and Polyclonal Antibodies ResearchPeptidase Inhibition and AnalysisHER2/EGFR in Cancer Research